Validation experiments using flow cytometry (FACS) was performed on total PBMCs from n=40 individuals in our cohort (25 LC, 15 non-LC). Sample preparation and cell revival were performed as described above for CyTOF preparation, and analyzed at baseline, or following SARS-CoV-2 peptide stimulation. For staining, cells were first treated with Zombie UV
™ or Zombie NIR
™ (BioLegend) as viability indicators, and then blocked with Human TruStain FcX
™ (BioLegend). FACS antibodies that were used in this study are shown in
Table S7. For intracellular staining, cells were fixed with 2% PFA and incubated with
Foxp3 fix/perm buffer (eBioscience) per manufacturer’s instructions, following completion of surface antibody staining. The BD Horizon
™ Brilliant stain buffer (BD Biosciences) was used according to manufacturer’s instructions when staining with antibodies conjugated to brilliant dyes. All cells were fixed in 2% PFA prior to analysis on a
Fortessa X-20 (BD Biosciences). UltraComp eBeads
™ Compensation Beads (Invitrogen) served as a single fluorescence dye control, and ArC
™ Amine Reactive Compensation Beads (Invitrogen) served as a loading control for live/dead cell staining. FCS files were exported into FlowJo (BD, version 10.9.0) for further analyses. FACS data were arcsinh-scaled prior to analyses.
Yin K., Peluso M.J., Luo X., Thomas R., Shin M.G., Neidleman J., Andrew A., Young K., Ma T., Hoh R., Anglin K., Huang B., Argueta U., Lopez M., Valdivieso D., Asare K., Deveau T.M., Munter S.E., Ibrahim R., Ständker L., Lu S., Goldberg S.A., Lee S.A., Lynch K.L., Kelly J.D., Martin J.N., Münch J., Deeks S.G., Henrich T.J, & Roan N.R. (2023). Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv.